ecancermedicalscience

Case Report

Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

18 Oct 2012
G Masci, A Losurdo, C Gandini, I Garassino, L di Tommaso, R Torrisi, M Zuradelli, A Santoro

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a prolonged response to therapy. This case report adds weight to known data on metronomic treatment and supports further investigation of this therapy.

Related Articles

Mayada Mustafa Ahmed, Bashier Ibrahim Osman, Alnada Abdalla Mohamed Ibrahim, Maisa Elfadul, Mounkaila Noma, Kamal Eldein H Mohamed, Nazik Elmalaika Obaid Seid Ahmed Husain
Carolina Muñoz Olivar, Sylvia Ramis, Francisco Acevedo, Benjamin Walbaum, Karol Ramirez, Gina Merino, Barbara Samith, Isabel Saffie, Carolina Zarate, Lidia Medina, Constanza Figueroa, Francisco Dominguez, Mauricio Camus, Catalina Vargas, Maria Elena Navarro, Dravna Razmilic, Marisel Navarro, Constanza Pinto, Catalina Muñoz, Raul Martinez, Manuel Manzor, Cesar Sanchez
Ariel Cherro, Laura Aresca, María Susana Ciruzzi, Alejo Agranatti, María Fernanda Montaña, Cynthia Frahne, Jaqueline Cimerman
Meghal Prajapati, Anil Kumar Goel, Yamini Patel, Divyeshkumar Rana, S Lokesh, Pooja Panchal, Dhruv Rathod, Chandramouli Ramalingam, Kondeti Ajay Kumar